These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20132238)

  • 1. Tumour-selective antivascular effects of the novel anti-mitotic compound A-318315: An in vivo rat regional haemodynamic study.
    Segreti JA; Brooks KA; Marsh KC; Bauch JL; Lan Y; Thomas Lin C; Rosenberg SH; Sham HL; Reinhart GA; Cox BF; Polakowski JS
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):636-40. PubMed ID: 20132238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor selective antivascular effects of the novel antimitotic compound ABT-751: an in vivo rat regional hemodynamic study.
    Segreti JA; Polakowski JS; Koch KA; Marsh KC; Bauch JL; Rosenberg SH; Sham HL; Cox BF; Reinhart GA
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):273-81. PubMed ID: 15173957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.
    Luo Y; Hradil VP; Frost DJ; Rosenberg SH; Gordon GB; Morgan SJ; Gagne GD; Cox BF; Tahir SK; Fox GB
    Anticancer Drugs; 2009 Jul; 20(6):483-92. PubMed ID: 19398903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
    Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA
    Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats.
    Cox BF; Smits GJ
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1492-500. PubMed ID: 8667215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of aprotinin on the mean arterial pressure, carotid artery blood flow, and hindlimb vascular resistance in the live rat, and pulmonary vascular resistance in the isolated perfused rat lung.
    Jahr JS; Kaye AD; Kang B; Feng CJ; Nossaman BD
    J Med; 1995; 26(1-2):31-42. PubMed ID: 7561529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
    Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T
    Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
    Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ
    Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
    Smits JF; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate.
    Hua J; Sheng Y; Pinney KG; Garner CM; Kane RR; Prezioso JA; Pettit GR; Chaplin DJ; Edvardsen K
    Anticancer Res; 2003; 23(2B):1433-40. PubMed ID: 12820406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of BW245C, a prostaglandin dp receptor agonist, on systemic and regional haemodynamics in the anaesthetized rat.
    Koch KA; Wessale JL; Moreland R; Reinhart GA; Cox BF
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):931-5. PubMed ID: 16405449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
    Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
    J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
    McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
    Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model.
    Allison B; Yang Y; Pourrier M; Gibson JK
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):463-8. PubMed ID: 21283020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour blood flow modification by endothelin-related peptides in the rat HSN fibrosarcoma.
    Bell KM; Prise VE; Chaplin DJ; Tozer GM
    Br J Cancer Suppl; 1996 Jul; 27():S161-3. PubMed ID: 8763871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.